3.0 release brings change visualization to NeuroQuant®

With the new release of NeuroQuant® 3.0, users will now have access to the change visualization output, previously available only through LesionQuant. Now compare two 3D T1 scans to detect and highlight the volumetric change within an easy to interpret heat map overlay. Users will see voxel-specific changes between the two scans highlighted in a color-coded heat map returned to the PACS system as a DICOM volume. The detailed 3D overlay provides high-resolution images to inform physicians of very subtle changes such as ventricle expansion, tissue atrophy and swelling that would otherwise be undetected by the human eye.

 

Sagital NQChange    NQChange Visualization AxialNQChange Visualization

 

The change analysis also highlights areas of significant volume changes that may be a result of medication, injury, or disease progression. This output fully integrates into the existing workflow and provides a DICOM overlay of co-registered and aligned images between time points.

To generate a change visualization output for NeuroQuant® or LesionQuant, the raw data from the baseline scan must be available in the NeuroQuant® database. If the baseline data is available, NeuroQuant® and LesionQuant will automatically generate change visualization outputs if the scan protocols are comparable. If baseline data is not available, the user will upload the baseline scan 3D T1 (and FLAIR for LesionQuant) for analysis, then upload the current time point data.

NeuroQuant® 2.3 will continue to be available to all customers however all new features will only be available with NeuroQuant® 3.0. Learn more about the new and improved features NeuroQuant® 3.0 can bring to you and your patients.

Ready to upgrade to 3.0? Click here to request migration to NeuroQuant® 3.0.

 

More Resources

04/22/2025

Cortechs.ai Receives Health Canada Approval to Expand Sales of AI-Powered Imaging Solutions in North America

Cortechs.ai receives Health Canada approval to expand its AI imaging solutions into Canada, advancing diagnostic precision and patient care.

04/02/2025

Pediatric Neuroimaging Insights: The NeuroQuant® Age Range Series

Brain volumetrics play a pivotal role in understanding pediatric neurological development. Explore how NeuroQuant® enhances neuroimaging from ages 3 to 100.

03/31/2025

How NeuroAlign CT Subtraction Maps Enhance Detection and Confidence in Neuroradiology

What if head CT assessment could be even faster and more accurate? Subtraction maps allow for improved detection and visualization of subtle interval changes.

03/27/2025

Cortechs.ai Joins Forces with Kryptonite Solutions as a Distribution Partner to Expand AI-Driven Neuroimaging Access in India

We are pleased to announce a strategic partnership with Kryptonite Solutions to distribute our innovative portfolio across India.

03/20/2025

Cortechs.ai Announces Strategic Distribution Partnership with Medical Horizons to Expand Presence in Italy, Turkey, and the Middle East

We are pleased to announce a strategic distribution partnership with Medical Horizons, a premier AI-powered medical device distributor based in Florence, Italy.

03/18/2025

Unlocking the Power of AI Imaging in Multiple Sclerosis: How NeuroQuant® MS Enhances Lesion Detection and Monitoring

Unlock the power of AI-driven imaging with NeuroQuant® MS—enhancing lesion detection, monitoring, and personalized care for Multiple Sclerosis.
Scroll to Top